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ζ-Associated protein of 70 kD (ZAP-70) and 
spleen tyrosine kinase (Syk) are cytoplasmic 
protein tyrosine kinases involved in immuno-
receptor signaling. Both have been implicated in 
TCR signaling during thymocyte develop-
ment. The ZAP-70–defi cient mouse displays 
an absolute block in thymocyte development at 
the positive selection stage (i.e., the transition 
from the CD4+CD8+ double-positive [DP] to 
the CD4−CD8+ or CD4+CD8− single-positive 
[SP] stages), whereas the Syk-defi cient thymus 
shows no obvious block (1, 2). Strikingly, the 
combined loss of both kinases results in an 
 absolute block at the earlier TCRβ selection 
stage, a stage where thymocytes are selected for 
rearrangements of in-frame TCRβ chains (3). 
This fi nding, combined with an absolute re-
quirement for Src family kinase signaling (4, 5), 
is consistent with the canonical two-step im-
munoreceptor pathway originally described in 
T cell lines that also apply to this early step 
of thymocyte development (6–8). That is, se-
quential Src family kinase–dependent immu-
noreceptor tyrosine-based activation motif 
phos phorylation, followed by Syk family kinase 
signaling, is required for normal progression 
through β selection.
Successful rearrangement and expression of 
an in-frame TCRβ chain creates a protein that 
pairs with the invariant pre-Tα chain to form a 
pre-TCR. The pre-TCR engages the already 
expressed signaling machinery in the immature 
thymocyte in an apparently ligand-independent 
manner and generates a signal (9). It is widely 
assumed that simple expression of a functional 
pre-TCR at the β selection stage generates a 
signal that, combined with other signals such as 
TNF and Notch signaling, is suffi  cient to gen-
erate normal DP cells that are ready to undergo 
thymic selection (10–13). The pre-TCR signal 
has many purposes, including rescue from apop-
tosis, proliferation, and diff erentiation among 
others (10, 12). Mice unable to rearrange TCR 
genes or signal through the pre-TCR illus-
trate the critical importance of β selection. For 
example, rag−/− (recombinase-activating gene 
[Rag] KO) thymocytes cannot rearrange TCRβ 
or TCRγδ loci and are completely arrested at 
this stage with thymic cellularity reaching only 
2% that of the WT.
 The β selection stage is readily identifi ed in 
the mouse. Thymocytes from mice defi cient in 
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The spleen tyrosine kinase (Syk) and ζ-associated protein of 70 kD (ZAP-70) tyrosine 
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components of pre-TCR signaling are blocked at the CD3−
CD4−CD8−CD11b−CD19−DX5−Gr1−TCRγδ−CD44−
CD25+ (Lin−) double-negative (DN) 3 stage. Thus, rag−/− 
thymo cytes, or those lacking the nonredundant adapters Src 
homology 2 domain–containing leukocyte phosphoprotein of 
76 kD (Slp-76) or linker for activation of T cells (LAT), 
or enzymes such as Src or Syk family kinase members, are 
completely blocked at DN3 (3–5, 14–16). Moreover, because 
no signal is generated, the DN3 cells remain small and quies-
cent, unable to enter the cell cycle and achieve a blast-phase 
morphology, as occurs in normal development. Although the 
double KO (dKO) of ZAP-70 and Syk suggests a degree of 
redundancy between these two kinases, it is not known whether 
ZAP-70 or Syk is preferentially used during β selection.
After TCRβ selection and pre-TCR signaling, thymo-
cytes proceed through a sequence of proliferation and diff eren-
tiation before reaching a second critical selection checkpoint 
at the CD4+CD8+ DP stage. Similar to the DN3 pre-TCR 
signaling stage, thymic selection also critically depends on the 
TCR signaling machinery. Positive (and negative) selection 
depends on ZAP-70, TCRα, and MHC molecules, as shown 
by the respective KOs (17). However, absolute blocks at the 
DN3 stage may preclude assessing a role at later stages. For 
example, it had been assumed that Slp-76 is required for 
positive/negative selection and peripheral T cell activation, 
yet direct evidence was lacking for thymic selection until 
recently (18). Similarly, the pre-TCR may be necessary and 
functioning at later stages, such as between DN3 and DP, 
and this may be masked by absolute blocks at DN3 (Slp-76 
and LAT KOs) or progression to the DP stage because of kinase 
family redundancy (Fyn and Lck, as well as ZAP-70 and Syk, 
KOs). The transcription factors basic helix-loop-helix, TCF/
LEF, and Egr families and the nuclear hormone receptor 
RORγ are implicated (for review see reference 19) during 
these stages. These factors are thought to act at the immature 
SP (ISP) CD8+CD4−/loTCRβlo stage immediately preceding 
the DP stage or at the DP stage, before selection. Aside from 
these factors, there are few reports of mutations that interfere 
with development between the DN3 and DP stages. It is 
possible that proper pre-TCR signaling using either Syk 
or ZAP-70 protein is necessary for normal transcription fac-
tor induction and progression during the stages between DN3 
and DP.
To investigate the individual roles of Syk and ZAP-70 
during early thymocyte development, we competed thymo-
cyte progenitors from syk−/− and zap70−/− donors against 
each other as they repopulated a normal thymus after deplet-
ing the endogenous thymocytes. We found that only syk−/− 
thymocytes are specifi cally impaired in progressing past the 
DN3 β selection stage of development despite up-regulation 
of ZAP-70 within TCRβ-selected DN3. Unexpectedly, 
only zap70−/− thymocytes are uniquely impaired after the 
DN3 and before the DP stages, despite continued Syk expres-
sion within the DN4 and ISP stages. Our experiments indi-
cate unexpected and distinct functions for Syk and ZAP-70 
during early development and suggest that pre-TCR/TCR 
signaling continues during the DN4, ISP, and DP stages to 
generate normal numbers of DP cells before they undergo 
thymic selection.
RESULTS
Syk and ZAP-70 proteins provide thymocytes 
with differential fi tness during development
We used competitive repopulation of the thymus in irradi-
ated hosts as a sensitive and discriminating assay for in vivo 
thymocyte development. Such a competitive repopulation 
strategy might, for example, reveal subtle diff erences in pro-
liferative capacities or usage of limiting growth factors. We 
used stem cell progenitors from zap70−/− and syk−/− em-
bryos or animals and distinguished the two donor populations 
based on the congenic markers CD45.1 and CD45.2 (20). 
This strategy is outlined in Fig. S1 (available at http://www
.jem.org/cgi/content/full/jem.20070405/DC1). Lethal irra-
diation of WT hosts and reconstitution with donor stem cells 
resulted in 	98–99% replacement of all thymocytes within 
4 wk by all genotypes tested (unpublished data). The 1–2% 
residual host cells detected were always within the mature SP 
subsets. All other subsets were routinely replaced >99% by 
donor-derived cells.
Because thymocyte development occurs as a well-
 characterized series of stages, the percentage represented by 
each genotype at a given stage is indicative of the develop-
mental fi tness of the thymocyte up until that stage. Any impai r-
ment or enhancement in fi tness would result in a decrease or 
increase, respectively, at the next stage of development. The 
competitive repopulation of the thymus using syk−/− versus 
zap70−/− progenitors is shown in Fig. 1. Injection of equal 
amounts of BM or fetal liver (FL) resulted in roughly equal 
representation at the earliest DN2 and DN3 stages identifi ed. 
Equal representation of syk−/− and zap70−/− thymocytes 
within these earliest subsets suggests that neither kinase has an 
important unique function in development until at least the 
DN3 stage. In striking contrast, the two populations are dif-
ferentially represented at multiple stages immediately after 
DN3. At least two changes seemed to occur: Syk−/− thymo-
cytes became underrepresented at the DN4 stage when com-
pared with DN3, and after that, zap70−/− thymocytes became 
underrepresented while progressing from the DN4 to the DP 
stage. These could be explained in multiple ways. One pos-
sibility is that Syk provides a positive regulatory role at 
the DN3 stage of development (thus, syk−/− accumulates 
at DN3), whereas ZAP-70 provides a diff erent positive regu-
latory role at the DN4 and ISP stages. Another possibility is 
that ZAP-70 provides a negative regulatory role at the DN3 
stage, allowing zap70−/− thymocytes a greater fi tness advan-
tage in transitioning from DN3 to DN4. Similarly, syk−/− 
thymocytes may have an advantage in progression from DN4 
to DP. Our results diff er from previous work that had re-
ported that ZAP-70’s only unique function in thymocyte de-
velopment was during thymic selection, at the DP stage (21). 
We also saw this eff ect in our assays, as ZAP-70 defi ciency 
resulted in a complete block in positive selection as shown by 
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the decrease in representation of zap70−/− thymocytes be-
tween the DP and SP4 stages. These data reveal that Syk and 
ZAP-70 uniquely contribute to the developmental fi tness of 
early thymocytes at distinct stages well before positive selec-
tion occurs.
Syk And ZAP-70 proteins are inversely expressed 
during early thymocyte development
To understand the basis of diff erential fi tness between syk−/− 
and zap70−/− developing thymocytes, we sought to deter-
mine the expression patterns of both kinases during all stages 
of thymocyte development. To investigate the expression pat-
terns of Syk and ZAP-70 kinases, we quantitated the relative 
levels of mRNA in all thymocyte subsets. We sorted cells and 
used real-time fl uorigenic RT-PCR to quantitate mRNA 
expression. The DN subsets were isolated based on standard 
phenotyping: CD25+CD44+ (DN2), CD25+CD44− (DN3), 
and CD25−CD44− (DN4). We found that Syk mRNA 
was robustly expressed at DN2, whereas Zap70 was hardly 
detectable, almost 100-fold less than in peripheral T cells 
(Fig. 2 A). Zap70 is fi rst up-regulated within the DN3 popu-
lation and increases thereafter. Interestingly, Syk mRNA ex-
pression decreases from DN3 to DN4 and spikes at the DP 
stage, before decreasing again at the SP stage. This pattern of Syk 
family kinase mRNA expression is consistent with another 
recent study (22).
After characterizing mRNA expression, we investigated 
ZAP-70 and Syk protein expression. We previously charac-
terized Syk (23), but not ZAP-70, protein expression during 
thymocyte development. To do so, we conjugated an mAb 
previously made in this laboratory against ZAP-70 (24) to 
Alexa Fluor dyes. This gave a 25-fold increased signal in T ver-
sus B cells. This was specifi c, as NK cells and the 1–2% 
 remaining T cells from zap70−/− mice provided a negative 
control (unpublished data).
Expression of ZAP-70 and Syk in all stages of thymocyte 
development is shown in Fig. 2 B. The overall pattern of ex-
pression of Syk agrees with our previous fi ndings (23). We 
found ZAP-70 expressed at low levels during the earliest 
stages of development. In fact, robust ZAP-70 expression is 
not seen until DN4, which exhibits a four- to fi vefold 
increase in ZAP-70 levels compared with DN3. ZAP-70 
protein continues to increase thereafter (Fig. 2, B and C). 
CD8+TCRβhi SP thymocytes had slightly more ZAP-70 
than CD4+ SP thymocytes, owing to their slightly larger size 
(unpublished data).
We sorted CD25+ DN cells (pooled DN2/3) and per-
formed immunoblot analysis on lysed cells (Fig. 2 D) to con-
fi rm low ZAP-70 protein expression in DN3. We also sorted 
CD25− DN cells and compared these cells with various lym-
phoid cell lines. This analysis confi rmed that Syk is easily de-
tectable within DN2/3 cells, whereas ZAP-70 is expressed at 
low levels. Overall, Syk and ZAP-70 are reciprocally ex-
pressed across thymocyte development, where Syk is highly 
expressed in early development and ZAP-70 is highly ex-
pressed in later development. However, there is considerable 
overlap where both kinases are detectable, including the DN3, 
DN4, and ISP stages.
Syk is necessary for normal progression past DN3 only
Intracellular fl ow cytometry, combined with our initial com-
petitive repopulation assays, suggested that Syk may be serv-
ing a positive regulatory role at DN3 and serves a reduced role 
from the DN4 through the DP stages as its protein expression 
disappears. To test this possibility, we competed Syk-defi cient 
progenitors against the WT in a repopulating thymus. This 
ruled out confounding eff ects brought on by competing against 
zap70−/− thymocytes. Because Syk is highly expressed in 
DN1 and possibly earlier, we assayed representation of DN1 
after varying the ratios of FL injected into the host as a mea-
sure of the fi tness of colonizing the thymus. Analysis of DN1 
representation revealed no substantial changes in donor ratios 
(Fig. 3 A) compared with what was injected. Therefore, colo-
nization is not substantially aff ected in syk−/− thymocyte pro-
genitors after lethal irradiation of the host, consistent with our 
results in Fig. 1.
We then assessed donor representation within subsequent 
stages of thymocyte development. Fig. 3 B shows that syk−/− 
thymocytes were consistently underrepresented only after DN3. 
This was true at all starting ratios. Interestingly, syk−/− thymo-
cytes were overrepresented within the CD4+ SP and CD8+ 
SP TCRhi populations (not depicted). This was true whether 
the irradiated host was CD45.1+ or CD45.2+, suggesting that 
syk−/− thymocytes may be more fi t than the WT at progress-
ing from the DP to the SP stage.
We focused our experiments on whether Syk defi ciency 
impairs TCRβ rearrangement and protein expression. DN3 
cells from WT and syk−/− thymocytes had equal percentages 
of intracellular TCRβ (TCRβic+) cells (Fig. 3 C). However, 
cell-cycle progression was impaired 40–50% in syk−/− DN3 
(Fig. 3 D), as shown by decreased BrdU incorporation. 
Figure 1. Syk-defi cient and ZAP-70–defi cient thymocytes show 
differential fi tness during development. Competitive repopulation 
assay in which syk−/− and zap70−/− BM cells were injected at a 1:1 ratio, 
and the reconstituted chimeric thymus was analyzed 6 wk later. Syk-
defi cient BM was created by reconstituting lethally irradiated WT mice 
with syk−/− FL and harvested after 8 wk. Data are representative of four 
mice. Bars depict means ± SD. The experiment was repeated using FL 
from both genotypes with similar results.
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In contrast, DN4 cell cycling was comparable in syk−/− and 
WT cells, indicating less of a role for Syk at this stage. Because 
apoptosis is diffi  cult to detect within a steady-state thymus, we 
could not detect reproducible diff erences in apoptosis  between 
genotypes within the mixed chimeras. Therefore, our competi-
tive repopulation experiments indicated that Syk-defi cient thy-
mocytes have a fi tness defect compared with WT thymocytes at 
the DN3 stage, and loss of Syk is only partially compensated for 
by ZAP-70. Furthermore, although TCRβ rearrangement 
seems to occur normally, Syk defi ciency impairs cell-cycle pro-
gression at the DN3 stage.
Syk is preferentially required for the initial DN3-E 
pre-TCR signal that leads to DN3-L blast phase
DN3 cells are a mixture of at least two populations: small cells 
actively rearranging TCRβ loci (DN3-E or DN3a) and large 
cells that have successfully expressed a TCRβ chain, initiated 
pre-TCR signaling, and entered a cell cycle (DN3-L or 
DN3b) (25, 26). Our repopulation assays suggested that Syk 
is required for normal progression through one or both of 
these stages. To investigate which stage is aff ected, we ana-
lyzed TCRβic+ expression and compared it to cell size to 
discriminate DN3-E and DN3-L cells within WT and syk−/− 
Figure 2. ZAP-70 and Syk protein are differentially expressed 
during thymocyte development. (A) The bar graphs indicate means ± SD 
of real-time quantitation of Zap70 and Syk mRNA from the sorted cells 
(>98% purity) relative to a control gene (Hprt). The entire sort and RNA 
quantitation was performed twice using two groups of 20 mice with similar 
results. (B) Flow cytometric histograms showing ZAP-70 and Syk protein 
expression in all major thymocytes subsets. Shaded histograms show an 
isotype-matched mouse IgG1 conjugated to the same fl uorescent dye. 
(C) Bar graphs quantitatively present the means ± SD of ZAP-70 and Syk 
mean fl uorescence intensity (MFI) protein expression, as shown in B, from 
three adult animals. This was repeated at least 16 times with similar 
results. Black bars indicate background IgG1 mean fl uorescence intensity. 
(D) Immunoblot of ZAP-70 and Syk protein expression in sorted CD25+ 
(DN2/3) and CD25lo/− (DN1/4) DN thymocytes at >98% purity (not 
depicted) and various lymphoid cell lines. Densitometry was used to quan-
titate the relative expression levels of the kinases in each lane.
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thymocytes. For a given mouse, TCRβic+ correlated well 
with increased cell size in WT thymocytes. However, in 
syk−/− thymocytes within the same mouse, TCRβic+ did 
not correlate with increased cell size, where the DN3-L pop-
ulation was greatly reduced despite normal levels of TCRβic+ 
expression (Fig. 3 C; and Fig. 4, A and B). We performed 
a similar analysis of DN3 from WT and zap70−/− mixed 
chimeric mice (further discussed in the following section). 
Zap70−/− thymocytes had normal numbers of DN3-L cell 
formation after TCRβic+ expression. Similar results were 
seen in mice reconstituted with varying ratios, or that were 
noncompetitively reconstituted, and in nonreconstituted WT 
and zap70−/− mice. Collectively, these results indicate that 
Syk has a nonredundant function in early pre-TCR signaling 
and is needed for normal blast formation and cell-cycle pro-
gression after TCRβ selection and protein expression. Addi-
tionally, our mixed chimeric studies indicate that this defect is 
thymocyte intrinsic.
We next wished to directly characterize the biochemical 
nature of the initial pre-TCR signal in WT and syk−/− thy-
mocytes. However, traditional biochemical methods were 
prohibitive because of the paucity of DN subsets and the 
limitations of making suffi  cient chimeric mice. As an alter-
native to traditional biochemistry, we used fl ow cytometry 
to detect phosphorylation site–specifi c antibody staining in 
TCRβic− DN3-E cells before and after CD3 cross-linking 
as a correlate of kinase activation. The phospho–ZAP-70 
(Tyr319)/Syk (Tyr352) antibody used detects activated forms 
of both ZAP-70 and Syk. Small amounts of CD3 reach the 
surface of Rag1-defi cient DN3 cells (27), and we speculated 
that this would be true of normal TCRβic− DN3-E cells. 
Anti-CD3 stimulation of WT DN3-E thymocytes resulted 
in a twofold increase in phosphorylated Syk/ZAP proteins 
(Fig. 4 C, top left). Preincubating with PP2, an Src-kinase 
specifi c inhibitor, decreased the phospho-ZAP/Syk signal 
below background (not depicted), confi rming that the signal 
emanates from a CD3-Src kinase–dependent pathway. Simi-
lar stimulations of syk−/− DN3-E thymocytes revealed that 
any phosphorylation of ZAP-70 is undetectable (Fig. 4 C, 
top right). As a control, CD4+ SP thymocytes from WT and 
syk−/− thymocytes (which express equal levels of ZAP-70 
and no Syk) were equally phosphorylated on Syk family 
kinases after CD3 cross-linking. These data suggest that 
Syk, not ZAP-70, is preferentially activated downstream of 
Figure 3. Syk is uniquely required for optimal progression past 
DN3. (A) WT and syk−/− FL cells from E15.5 embryos were injected at 
various ratios into lethally irradiated B6 hosts, and the reconstituted chimeric 
thymus was analyzed 5–7 wk later. DN1 was characterized by further 
excluding CD25+ events while gating on CD44+CD117+. Data indicate 
three to fi ve mice per group in all experiments. Bars depict means ± SD. 
(B) The contribution of each genotype to major subsets after competing 
at 1:3 and 1:1 ratios. (C) Histograms showing representative intracellular 
TCRβ within DN3 for WT and syk−/− within the same mouse. Bar graph 
depicts means ± SD of percent TCRβ+. (D) Histograms of representative 
BrdU incorporation within DN3 and DN4 of WT and syk−/− within the 
same mouse 1.5 h after injecting 2 mg BrdU. Bar graph indicates means ± 
SD of BrdU+ syk−/− thymocytes as a percentage of the mean of BrdU+ 
WT thymocytes within the same mice.
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the CD3 complex within WT DN3-E cells and that this 
may account for the blast defect seen in syk−/− TCRβic+ 
DN3 thymocytes.
ZAP-70 has an unexpected and unique function in generating 
DP thymocytes before positive selection occurs
We next wished to further test whether ZAP-70 serves a 
positive regulatory role before positive selection. Our initial 
competitive repopulation experiments suggested that ZAP-70 
might provide two novel functions: a negative regulatory func-
tion at DN3 as well as a positive function immediately after 
DN3 and before positive selection. Unlike syk−/− thymocytes, 
zap70−/− thymocytes had no discernable fi tness impairment 
or enhancement at the DN3 stage, as measured by competi-
tive repopulation versus the WT (Fig. 5 A). Blast size, TCRβ 
rearrangement, and protein expression were similar to the 
WT, as was cell-cycle status in DN3 and DN4 cells (Fig. 5, 
B and C). These data suggest that ZAP-70 has no notable role 
(positive or negative) at the DN3 stage that is not compen-
sated for by Syk in the zap70−/− thymocyte during competi-
tive repopulation. Competitive repopulation revealed that SP 
thymocytes are lacking in zap70−/− thymocyte subsets, consis-
tent with the reported phenotype (21).
Surprisingly, zap70−/− thymocytes were also substantially 
impaired before the DP stage. Zap70−/− thymocytes were 
largely impaired even before the CD8+CD4−/loTCRβlo ISP 
stage (Fig. 5 A). Thus, competition of zap70−/− versus the 
WT and syk−/− versus the WT is entirely complementary with 
our results from directly competing syk−/− against zap70−/− 
(Fig. 1, Fig. 3, and Fig. 5). Collectively, these data suggest a 
novel positive regulatory function for ZAP-70 during the 
DN4, ISP, and DP stages and before positive selection, as well 
as a distinct positive role for Syk at DN3-E. The individual 
competitions against the WT argue against any enhanced fi t-
ness upon deleting the kinases and any obvious negative regu-
latory functions.
ZAP-70 is necessary for normal generation of DP thymocytes 
after cross-linking CD3 on Rag DN3 thymocytes
It is possible that ZAP-70 is not involved in pre-TCR signal-
ing but has some other function that is important and merely 
correlates with the pre-TCR+ cellular stage. For example, 
the pre-TCR may generate a single Syk-dependent signal at 
the DN3-E stage that leads to the expected 6–10 cell divi-
sions and characteristic gene expression changes, whereas 
ZAP-70 functions in a parallel but diff erent pathway. Alter-
natively, initial Syk-dependent pre-TCR signaling may give 
way to continuous ZAP-70–dependent pre-TCR and/or 
TCR signaling that is MHC independent between the DN3 
and DP stages.
To test this, we used an in vivo model of pre-TCR signaling. 
Rag1−/− (Rag) thymocytes can be induced to diff erentiate 
into DP thymocytes by in vivo stimulation with anti-CD3 
mAbs (27, 28). This process yields normal numbers of DP 
thymocytes and is dependent on kinases and the nonre-
dundant T cell adapters Slp-76 and LAT (14, 15). We injected 
increasing amounts of anti-CD3 into rag1−/− mice to deter-
mine whether DP development was titratable. Increasing 
amounts of anti-CD3 resulted in a dose-dependent  increase 
in total thymocyte production after 5 d and was primarily 
representative of DP production (Fig. 6 A, bar graphs). Abso-
lute DN4 production also increased with increasing antibody, 
whereas DN3 cells decreased (not depicted), probably owing 
to the slow rate of replacement from BM stem cells and 
increased diff erentiation to DN4. This assay allowed us to 
ask whether ZAP-70 is necessary for DP generation when 
we control the strength and specifi city of a pre-TCR–like 
signal. Anti-CD3 stimulation resulted in 7–10-fold less DP 
generation at all antibody concentrations in rag1−/−zap70−/− 
Figure 4. Syk defi ciency impairs initial DN3 pre-TCR signaling and 
blast formation in a cell-autonomous manner. (A, left) Histogram 
depicts cell size of DN3 cells before TCRβic expression. (middle) Histogram 
compares the cell size of syk−/− with WT TCRβic+ DN3 within one mixed 
chimeric mouse. (right) Histogram compares the cell size of zap70−/− 
with WT TCRβic+ DN3 within one mixed chimeric mouse. (B) Quantitation 
of data in A, where each genotype is represented by at least nine chimeric 
mice. Bars depict percent means ± SD of TCRβic+ that are DN3-L using 
an arbitrary gate equally applied to all samples. (C) Activation state phos-
phorylation of Syk family kinases is measured in small CD25+CD4−CD8− 
DN cells and CD4+CD8− SP after in vitro stimulation of unfractionated 
thymocytes with anti-CD3. Shaded histograms represent basal levels, 
whereas open histograms are after 2 min of stimulation. The experiment 
was repeated three times with similar results.
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(RagZAP dKO) compared with Rag controls. The diff erence 
slightly decreased with increasing antibody concentrations, 
suggesting that increased signaling can lead to a normaliza-
tion of cell numbers. Nevertheless, within the time frame 
studied, RagZAP dKO DN3 required 10-fold more antibody 
injected to achieve the same overall cellularity (compare Rag-
ZAP dKO at 100 μg with Rag at 10 μg). We believe this 
result represents a ZAP-70–dependent cell intrinsic defect 
downstream of the CD3 pathway before the positive se-
lection stage.
Representative phenotypic profi les of Rag and RagZAP 
dKO thymocytes are shown in Fig. 6 A (right). No overall 
increase in cell numbers was seen in RagZAP dKO stimulated 
with 10 μg anti-CD3, yet 68% of cells diff erentiated to the DP 
stage, refl ecting decreased absolute DN3s. At 30 μg, the fre-
quency of DP is similar with or without ZAP-70, yet the 
overall and DP cellularity is greater than sevenfold less with-
out ZAP-70. The absolute counts of DN3 and DN4 are also 
decreased two to fi vefold in RagZAP dKO compared with 
Rag mice (not depicted).
To determine how ZAP-70 aff ects generation of DP cells 
in this assay, we measured levels of BrdU incorporation and 
Annexin V binding as markers of cell-cycle status and apop-
tosis, respectively. For both genotypes, the fraction of cells in 
cell cycle in all subsets increased with increasing antibody. 
Examples of BrdU incorporation at 100 μg are shown in 
Fig. 6 B. RagZAP dKO DN3 and DN4 cells incorporated 
	80% BrdU compared with the respective Rag KO cells, 
and RagZAP dKO DP cells incorporated only 	35% (Fig. 6 B). 
Interestingly, the relative decrease in cell cycle in RagZAP 
dKO compared with Rag subsets was constant at various 
antibody concentrations. These data suggest that the fraction 
of cells in cell cycle in all subsets is proportional to the CD3-
mediated (i.e., pre-TCR) signal and that this signal depends 
on ZAP-70.
Because the initiating CD3-based signal was largely syn-
chronized in these experiments, assessment of apoptosis was 
possible. For both genotypes, apoptosis was highest after 
minimal stimulation with 10 μg anti-CD3 and is shown in 
Fig. 6 C. DN3, DN4, and DP subsets in RagZAP dKO were 
5–20-fold more apoptotic than Rag after 10 μg anti-CD3 
(Fig. 6 C). This diff erence decreased to approximately twofold 
in all subsets at greater antibody concentrations. Thus, unlike 
cell cycle, the eff ect of ZAP-70 on survival was proportional 
to the pre-TCR signal strength but appeared to be threshold 
dependent. The cell-cycle and apoptosis results suggest that 
ZAP-70 aff ects sustained pre- TCR signaling at all stages be-
tween DN3 and DP. We attempted similar experiments using 
rag1−/− and rag1−/−syk−/− reconstituted animals (into lethally 
irradiated rag1−/− hosts) but could not achieve reproducible 
levels of proliferation even within rag1−/− reconstituted mice. 
This may be because of radiation damage to the vascular sys-
tem of the host mouse (29) and ineffi  cient absorption of the 
anti-CD3 antibody.
ZAP-70 protein is robustly up-regulated only after 
DN3 cells have signaled through the pre-TCR
Because ZAP-70 is quickly up-regulated within DN4 cells, 
we speculated that ZAP-70 might be a direct target or indica-
tor of pre-TCR signaling. As noted before, DN3 thymocytes 
are a mixture of two populations: small, quiescent TCRβ-
 unrearranged DN3-E (DN3a) cells and large, cycling TCRβ-
rearranged DN3-L (DN3b) cells that are beginning the 
progression toward DP. Our RNA and initial fl ow cytometry 
Figure 5. ZAP-70 is unexpectedly and uniquely required before 
positive selection for normal generation of DP thymocytes in a cell-
autonomous manner. (A) Competitive repopulation assay in which 5 × 
106 WT and zap70−/− BM cells were injected at a 1:1 ratio, and the recon-
stituted chimeric thymus was analyzed 7 wk later. The experiment repre-
sents seven mice and was repeated three times with similar results. Bars 
depict means ± SD. (B and C) Intracellular TCRβ and BrdU incorporation 
were analyzed as in Fig. 3 (C and D).
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studies confl icted on whether ZAP-70 was fi rst expressed 
within the DN3 stage. We noticed that DN3 cells had a re-
producible positive shoulder of ZAP-70 protein but not Syk 
(Fig. 7 A), suggesting that subpopulations have diff erential 
ZAP-70 expression.
We focused on CD25+ DN2/3 thymocytes and assayed 
for simultaneous intracellular expression of TCRβ and either 
ZAP-70 or Syk protein to investigate the earliest detectable 
TCRβ-selected cell. TCRβic+ cleanly separated a ZAP-70lo/− 
cell from a ZAP-70+ population. Thus, TCRβ selection 
correlates with ZAP-70 protein up-regulation. The increase in 
expression was about threefold. The antibody specifi city was 
confi rmed by staining equivalent zap70−/− CD25+ DN cells 
(unpublished data). ZAP-70 correlated with cell size, which also 
correlated to TCRβic+ expression (Fig. 7 A; and unpub-
lished data). We also found that ZAP-70+ cells corresponded 
to CD27+ DN3b cells (unpublished data) (26).
These results suggested that ZAP-70 is up-regulated 
 af ter TCRβ is rearranged and expressed. Therefore, the up-
regulation of ZAP-70 may be a consequence of initial pre-
TCR signaling itself. To test this, we assayed ZAP-70 expression 
in Rag KO mice, as they are completely blocked in pre-TCR 
Figure 6. ZAP-70 is required for effi cient generation and survival 
of DP cells in Rag mice after in vivo anti-CD3 stimulation. 
(A, top) Graph shows total cellularity from rag1−/− and rag1−/−zap70−/− 
thy mocytes after 5 d of in vivo treatment with increasing anti-CD3 mAb. 
(bottom) Graph shows DP cellularity. Each group represents three mice. 
Representative plots illustrate the CD25/CD44 profi le of DN subsets and 
the CD4/CD8 profi le for DP subset. Numbers on DN plots indicate percent 
DN3. Numbers on DP plots indicate percent DP. (B) Representative 
 histo grams of incorporated BrdU after a 100-μg anti-CD3 treatment. 
(right) Bar graph shows the mean percentage of BrdU+ cells in 
rag1−/−zap70−/− subsets divided by the mean of rag1−/− control for 
0, 10, 30, and 100 μg mAb injected. (C) Histograms of Annexin V+ staining 
in rag1−/−zap70−/− dKO and rag1−/− thymocytes after anti-CD3 treat-
ment as depicted in B. Representative example shown is after 10 μg anti-
CD3. (right) Bar graph is similarly quantitated as in B.
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signaling and arrested at DN3. We injected increasing amounts 
of anti-CD3 mAb into Rag KO mice and examined ZAP-70 
expression in DN3, DN4, and DP cells. ZAP-70 protein in-
creased in a dose-dependent manner after anti-CD3 treat-
ment, as shown for DN4 in Fig. 7 B. Treated RagZAP dKO 
mice confi rmed the specifi city of the signal (Fig. 7, B and C). 
ZAP-70 protein is almost completely absent in resting Rag 
KO DN3, consistent with a requirement of an initial pre-TCR 
signal for robust ZAP-70 up-regulation. ZAP-70 expression 
increased in DN3, DN4, and DP cells (Fig. 7 C; and unpub-
lished data) after anti-CD3 injection in a dose-dependent 
manner. In addition, we assayed mice in which TCRβ rear-
rangement still occurs yet no signal is generated (lat−/− and 
lck−/−fyn−/−) and found no up-regulation of ZAP-70 or CD27 
and, therefore, no correlation with intracellular TCRβ 
(unpublished data). Collectively, our data suggest that ZAP-70 
is expressed at low levels in DN3-E thymocytes and is up-
regulated only after initial pre-TCR signaling in DN3-L. 
Thus, ZAP-70, along with CD27, is among the earliest tar-
gets or indicators of pre-TCR signaling. Developing thymo-
cytes have the unique feature by which initial Syk-dependent 
pre-TCR signaling at DN3-E quickly up-regulates ZAP-70, 
which then replaces Syk during sustained pre-TCR/TCR 
signaling during the DN3-L, DN4, ISP, and DP stages.
D I S C U S S I O N 
We have examined the expression patterns and in vivo func-
tions of the Syk family kinases Syk and ZAP-70 during early 
stages of thymocyte development. Syk−/− thymocytes are im-
paired in transitioning from DN3 to DN4 during competitive 
repopulation of the thymus. Analyses of mRNA abundance 
and intracellular fl ow cytometry indicated that early T cell 
progenitors express high levels of Syk and little or no ZAP-
70, and this remains true as cells commit to the T lineage 
pathway and become DN2 cells. After TCRβ selection has 
occurred, Syk is necessary in quiescent DN3-E (DN3a) cells 
for optimal initial pre-TCR signaling and entry into cell cycle 
and transition to DN3-L (DN3b) cells. ZAP-70 appears to 
have a preferred function during sustained pre-TCR signaling 
from the DN4 through the DP stages and aids in the normal 
expansion and diff erentiation of thymocytes despite concur-
rent Syk expression (through the ISP stage), after which posi-
tive selection occurs. In vivo stimulation with anti-CD3 mAbs 
in Rag mice confi rms that ZAP-70 uniquely functions down-
stream of the pre-TCR/TCR after the DN3-E stage and be-
fore DP selection. Loss of ZAP-70 mostly increases apoptosis 
levels but also decreases cell-cycle progression, especially at the 
DP stage. ZAP-70 expression is induced by the pre-TCR and 
is quickly up-regulated, coincident with CD27 when newly 
formed pre–T cells transition from DN3-E to DN3-L. Our 
data suggest the pre-TCR is a dynamic signaling module in 
which the signaling machinery is fundamentally altered dur-
ing development. We propose a model where Syk-dependent 
pre-TCR signaling is replaced with ZAP-70–dependent pre-
TCR signaling.
Previous work on the role of Syk in T cell development 
has been confl icting. Although the original KO papers sug-
gested that Syk had little role in development (1, 2), later re-
ports argued for either a unique role in TCRγδ development 
(30) or a more quantitative role in general T cell development 
(31). Our work is consistent with and expands on the re-
sults of Colucci et al. (31). That study found that DN3 cells 
were found at higher frequencies in syk−/− reconstituted 
mice, but they never competed syk−/− thymocytes versus the 
WT within a given mouse. Our studies allow direct compari-
son of the in vivo fi tness of syk−/− versus WT and syk−/− 
versus zap70−/− thymocytes within the same mouse, allow-
ing us to assess a quantitative impairment of the block and to 
conclude that the impairment is cell intrinsic. Further still, we 
demonstrate that ZAP-70 protein is poorly expressed within 
Figure 7. ZAP-70 protein is up-regulated after pre-TCR signaling. 
(A, top) ZAP-70 and Syk expression in all DN3 cells. (bottom) ZAP-70 pro-
tein compared with intracellular TCRβ chains within DN3s. (B, top) Dose-
dependent increased ZAP-70 expression in DN4 from rag1−/− mice 5 d 
after in vivo anti-CD3 injection. Shaded histogram is background DN4 
from PBS-treated mice. Other histograms show 10 μg (dotted line), 30 μg 
(dashed line), and 100 μg (open) of anti-CD3 treatment. (bottom) ZAP-70 
staining in control-treated rag1−/−zap70−/− dKO. (C) Bars depict quanti-
tation of means ± SD of ZAP-70 expression as shown in B and from the 
DN3 and DN4 subsets 5 d after in vivo anti-CD3 treatment in rag1−/− 
mice. Three mice were included for each condition. Overlaid black bars 
show means ± SD of ZAP-70 expression in similarly treated rag1−/−
zap70−/− dKO. This experiment was repeated twice with similar results.
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the DN3-E thymocytes, providing a logical explanation for 
syk−/− impairment.
Clearly, the pre-TCR has several well-defi ned functions 
(10). However, it is not established when these functions are 
used. Rescue from apoptosis may be necessary at the DN3-E 
stage but may also be necessary at every stage from DN3-L 
to DP for normal population expansion. One can imagine 
continuous pre-TCR signaling enabling maximal cell-cycle 
progression at all stages. In contrast to this, decreasing Rag 
activ ity and enforcing allelic exclusion of the TCRβ locus 
might only be necessary at the DN3-E stage. Some of these 
distinct functions have been shown to diverge downstream of 
the pre-TCR (19). We propose that they also temporally di-
verge during diff erentiation and expansion. ZAP-70 may pro-
vide continuous pre-TCR/TCR signaling during the DN3-L, 
DN4, ISP, and/or DP stages that is needed for optimal devel-
opment. Indeed, our data from in vivo–stimulated Rag mice 
demonstrate a strong correlation with anti-CD3 titration and 
ZAP-70 protein expression in all subsequent stages and abso-
lute DP generation. A similar function has recently been pro-
posed for Slp-76 (18). Continuous or constitutive pre-TCR 
signaling has been previously suggested. Studies of c-cbl−/− 
thymocytes suggest a continuous pre-TCR signal, as these 
cells have pre-TCRs that fail to be continuously internalized 
(32). DN4 cells are shown to activate NF-κB and NFAT 
downstream of the pre-TCR (33). A recent study demon-
strated temporal separation of Egr3 and RORγ induction after 
pre-TCR signaling, both of which are necessary for proper 
DP generation (34).
Other signaling components are also known to promote 
the proliferation and survival of DN and DP stages. Early 
stages of TCRβ selection require activation of Notch1 (11), 
p53 (35), FADD (36), and NF-κB (33, 37) pathways, among 
others, many of which are likely to be aff ected downstream of 
the pre-TCR. Because these molecules exert their eff ects at 
or immediately after the DN3 stage, they may be optimally 
activated by an Syk-dependent pre-TCR signal. However, 
Bcl-X, RORγ, and TCF/LEF all aff ect the survival of DP cells 
(38, 39), and they may be preferentially infl uenced downstream 
of a ZAP-70–dependent pre-TCR signal.
Notch and E2A activities precede/activate a host of T lin-
eage genes such as CD3 and Lck as early as stage DN1 (40–42). 
Therefore, it is surprising that ZAP-70, a largely T lineage–
specifi c protein, is not highly expressed until after the fi rst 
T lineage commitment checkpoint. One teleological explana-
tion may be that Syk is better able to transduce the initial pre-
TCR signal. This could either be a quantitative or a qualitative 
diff erence. Quantitatively, Syk is a more active kinase in vitro, 
causes more basal activation in T cells, and is less Src kinase–
dependent in T cell lines (for review see reference 43), which 
makes it less coreceptor dependent. In fact, the use of Syk for 
initial pre-TCR signaling may explain why the Lck KO is 
more leaky at pre-TCR signaling than at positive selection. 
Qualitatively, Syk may activate/inactivate specifi c genes. After 
initial pre-TCR signaling, ZAP-70 may be better able to trans-
duce continuous pre-TCR signals that are necessary for DN 
to DP transitioning. A previous study addressed whether 
Syk can substitute for ZAP-70 during positive selection by 
transgenic expression of Syk in a ZAP-70–defi cient mouse 
strain (44). These thymocytes overexpressed Syk after β selec-
tion and through the DP stage, suggesting that if Syk were 
overexpressed it could replace ZAP-70 during continuous 
pre-TCR signaling and DP expansion. However, the effi  -
ciency of DP generation was not determined, as these thymo-
cytes were not tested by competitive repopulation, leaving 
open the question of whether Syk could comparably replace 
all ZAP-70 functions if its expression was maintained from 
the DN3 to the DP stage. A recent study showed that Syk-
expressing B cells require the traditional mitogen-activated 
protein kinase kinase pathway for p38 activation, whereas 
ZAP-70–expressing T cells can also activate p38 in a novel 
mitogen-activated protein kinase kinase 3/6–independent 
manner (45). Thymocytes require that p38 not be activated 
during initial pre-TCR signaling (46), and Syk may suffi  ce. 
However, p38 becomes necessary for normal transitioning 
from the DN4 to the DP stage (47) and, thus, may be largely 
induced by ZAP-70–based pre-TCR signaling. We are cur-
rently testing these possibilities.
It is certainly possible that the diff erential fi tness of Syk and 
ZAP-70–defi cient thymocytes may, at least in part, be refl ec-
tive of the distinct expression levels of each kinase during these 
stages and may not be caused by a unique function of the 
given kinase at a certain stage. To formally test this would 
require a model system involving the competition of thymo-
cytes that express comparable levels of either ZAP-70 or Syk 
throughout thymic development on a null background for 
both kinases. Additionally, as TCRγδ cells diverge from 
TCRαβ cells at this DN3 stage because of a purported diff er-
ence in signal strength, the balance of γδ versus αβ T cells may 
be altered (48). A relative overexpression of ZAP-70, Syk, or 
both could alter this ratio by increasing the strength of the 
signal generated, thereby increase relative numbers of TCRγδ. 
Our comparative studies detail for the fi rst time the extent to 
which thymocytes diff erentially express both Syk family ki-
nases and show that such diff erential expression/and or function 
results in diff erential cellular fi tness during early development, 
where a Syk family–driven pre-TCR signal is necessary for 
normal DP expansion.
Interestingly, one unusual feature that distinguishes TCRα 
selection from the analogous Ig light chain selection is that 
TCRα chains are not allelically excluded (49, 50). Although 
the mechanisms leading to allelic exclusion are not well under-
stood, Syk may be uniquely suited to better transduce these 
signals in both lineages. Although ZAP-70 can perform some 
Ig heavy chain allelic exclusion (51), Syk is mostly responsible 
for this. It is unknown whether Syk or ZAP-70 diff erentially 
eff ect allelic exclusion of the TCRβ chain.
In summary, our studies identify a specifi c role for Syk 
during β selection and cell-cycle entry and uncover an unex-
pected relative requirement for ZAP-70 during early thymo-
cyte development. This occurs despite overlapping expression 
of both kinases within DN3-L and DN4 and ISP cells. Our 
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data are also consistent with a model in which Syk-dependent 
pre-TCR signaling induces ZAP-70 expression, which then 
replaces Syk for ZAP-70–dependent pre-TCR signaling as 
thymocytes progress toward the DP stage.
MATERIALS AND METHODS
Mice. Zap70−/− mice were backcrossed at least seven times onto the B6 
background. Syk+/− mice were carried as heterozygotes because of their ho-
mozygotic perinatality and were backcrossed at least 11 generations to B6. 
Syk+/− was later crossed to the BoyJ (B6 mice with the CD45.1+ congenic 
marker B6.SJL-Ptprca Pepcb/BoyJ) background for one generation. B6 and 
rag1−/− mice used for breeding were originally obtained from the Jackson 
Laboratory. B6 mice used as hosts for competitive repopulation were ob-
tained from Charles River Laboratories. BoyJ mice were purchased from 
Taconic and the Jackson Laboratory. For BrdU studies, 1–2 mg BrdU 
(Sigma-Aldrich) at 20 mg/ml was injected i.p. 1–2 h before killing the animal. 
All animals were housed in specifi c pathogen-free facility at the University 
of California, San Francisco according to university and National Institutes of 
Health guidelines.
Real-time RNA quantitation. RNA was extracted using TRIzol 
(Invitrogen), according to the manufacturer’s instructions. cDNA was cre-
ated using the Sensiscript protocol (QIAGEN). Primers and probes used 
for quantitative PCR span introns and were as follows. For mouse ZAP70, 
5′-G C A T G C G C A A G A A G C A G A T T -3′ (forward primer), 5′-G G G C C T-
C T C G C A T C A T C T C -3′ (reverse primer), and [6-FAM]C T T T G T C G G C-
C T T C T C T G T G C C C T G [BHQ1~Q] (probe) were used. For mouse Syk, 
5′-C T G G T T C C A T G G C A A C A T C T C -3′ (forward primer), 5′-T G G C C-
C T G A T C A G G A A T T T T C -3′ (reverse primer), and [6-FAM]T G A C C C T-
A T G A G G A C C G T C T G C T C T G A T [BHQ1~Q] (probe) were used. HPRT 
primers and PCR conditions were previously described (52).
Immunoblotting. Cell lysates were prepared using a 1% NP-40 lysis buff er 
with inhibitors and transferred to membranes after SDS-PAGE, as previously 
described (53). The A20 B cell line, Jurkat and P116 (ZAP-70–defi cient) 
cells, and the pre–T cell lines Sciet27 and SCB29 were used as ZAP-70– and 
Syk-expressing lymphoid cell lines. Lysates were corrected for protein con-
tent before loading. Antiactin mAb was obtained from Sigma-Aldrich. Lanes 
were quantitated using an Image Station (model 440DF; Kodak) and ID im-
age analysis software (version 3.5; Kodak).
Competitive repopulations and chimeras. For competitive repopula-
tion assays, FL versus FL or BM versus BM cells were injected i.v. into le-
thally irradiated B6 or BoyJ hosts, and reconstituted thymi were analyzed 
4–8 wk later. FL was from timed pregnancies at E15.5–16.5, and BM was 
from 8–12-wk-old adults. Syk−/− embryos were visually identifi ed and con-
fi rmed by either PCR or fl ow cytometry of reconstituted blood. For some 
experiments, syk−/− FL was used to generate chimeric mice, and the result-
ing BM was used for competing or reconstituting irradiated hosts. No diff er-
ences were seen using these BM compared with FL. WT recipients were 
irradiated with two doses of 600 rads, 3–5 h apart. Mixed FL chimeras were 
injected i.v. at ratios of 1:0, 0:1, 1:3, 3:1, 1:9, or 9:1. Each FL was resus-
pended in 1 ml media, and 200 μl (mixed or not) was used per mouse. For 
BM, 5 × 106 total cells were injected i.v. into each mouse. Males were used 
as recipients for most experiments, and females were used for some with no 
qualitative diff erences. Within an experiment, all hosts were sex and age 
matched and were between 5–10 wk old.
Antibodies and fl ow cytometry. Thymi were separated to single-cell 
suspensions using glass slides. 1–3 × 106 cells were used for each stain. mAbs 
against CD3, CD4, CD8, CD11b, CD19, and Gr-1 were used to exclude 
lineage-committed cells and delineate DN thymocytes and were conjugated 
to either PE or allophycocyanin (APC; BD Biosciences and eBioscience, re-
spectively). Biotin-DX5, -TCRγδ and -CD69 (BD Biosciences) with strep-
tavidin-APC or -PE were used to amplify the signal and/or exclude these 
cells. For Syk and ZAP-70 quantifi cation in thymocyte subsets, DN1 was 
defi ned as Lin− CD44+CD117+CD25−. T and B cells were from the LN 
and spleen and defi ned by CD3+CD19− for T cells and CD3−CD19+ for B 
cells. CD25, CD44, CD117, CD45R, and TCRβ (BD Biosciences) were 
conjugated to PE, PE-Cy5.5, or PerCP-Cy5.5 and FITC and further char-
acterized DN subsets. mAbs against CD45.1 and CD45.2 were conjugated 
to FITC, PE, or APC. mAbs against mouse/human ZAP-70 1E7 (24) and 
mouse Syk 5F5 (23) were conjugated to Alexa Fluor 488 or Alexa Fluor 647 
at fl uorophore/protein ratios of 6.5–7:1 or 5:1, respectively, using the manufac-
turer’s instructions (Invitrogen). Anti-BrdU was purchased from Invitrogen. 
Annexin V–FITC was obtained from Caltag. Fc binding was blocked using 
anti-CD16/32 2.4G2 (Harlan). For intracellular staining, cells were surfaced 
stained; fi xed in Fix and Perm Medium A (Caltag); stained for intracel-
lular ZAP-70, Syk, TCRβ, BrdU, or Lck with Fc block for 30–60 min 
in medium B (Caltag); washed with Perm/Wash (BD Biosciences); and 
fi xed. BrdU staining also included 4.1 mM CaCl2 and 20 U DNaseI (Roche). 
For phospho-ZAP/Syk analysis, cells were stimulated with 20 μg/ml anti-
CD3 (2C11), followed 20 s later by 50 μg/ml goat anti–hamster (Jackson 
ImmunoResearch Laboratories) secondary cross-linker and fi xed to terminate 
stimulation. Cells were permeablized using 90% ice-cold methanol for 30 min, 
stained with 2 μl phospho–Zap-70 (Tyr319)/Syk (Tyr352) antibody (Cell 
Signaling) for 1 h, stained with surface markers and donkey anti–rabbit–PE 
(Jackson Immunoresearch Laboratories) for 1 h, and fi xed. Data were coll-
ected on a FACSCalibur (BD Biosciences) and analyzed using FlowJo soft-
ware (TreeStar, Inc.). For RNA and immunoblot analysis,  cellular subsets 
were sorted using a sorter (MoFlo; DakoCytomation).
Anti-CD3 injections. 8–12-wk-old rag1−/− and rag1−/−zap70−/− mice 
were used for in vivo anti-CD3 treatment. Anti-CD3 mAb 2C11 was in-
jected i.p. at 10, 30, or 100 μg/animal diluted to 500 μl in PBS, and mice 
were killed and analyzed 5 d later. All experiments were repeated at least 
twice with similar results, and data are represented as the mean ± SD. For 
rag1−/− and rag1−/−syk−/− experiments, chimeric mice were made from FL 
and were used 5–6 wk after reconstitution.
Online supplemental material. After stem cell transfer and reconstitu-
tion, competitive repopulation was assessed as shown in Fig. S1. To ensure 
an unbiased assessment, all subpopulations were identifi ed fi rst, followed by 
interrogation of the CD45 allele marker. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20070405/DC1.
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